The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Zotarolimus-eluting stent-induced hypersensitivity pneumonitis

  • Shin, Hong-Won (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) ;
  • Nam, Chang-Wook (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) ;
  • Kim, Hyungseop (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) ;
  • Hur, Seung-Ho (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) ;
  • Kim, Yoon-Nyun (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) ;
  • Kim, Kwon-Bae (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) ;
  • Kwon, Kun-Young (Department of Pathology, Keimyung University Dongsan Medical Center)
  • Published : 2013.01.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-2092. https://doi.org/10.1016/j.jacc.2005.02.086
  2. Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47:175-181. https://doi.org/10.1016/j.jacc.2005.07.071
  3. Ahn YS, Byun DW, Joo JH, et al. A case of familial hypersensitivity pneumonitis. Korean J Med 1994;46:124-129.
  4. Howard L, Gopalan D, Griffiths M, Mahadeva R. Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate. Chest 2006;129:1718-1721. https://doi.org/10.1378/chest.129.6.1718
  5. Wong P, Leung AN, Berry GJ, et al. Paclitaxel-induced hypersensitivity pneumonitis: radiographic and CT findings. AJR Am J Roentgenol 2001;176:718-720. https://doi.org/10.2214/ajr.176.3.1760718

Cited by

  1. Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis vol.7, pp.None, 2013, https://doi.org/10.4172/1747-0862.1000065
  2. Hypersensitivity Reaction in the US Food and Drug Administration–Approved Second-Generation Drug-Eluting Stents : Histopathological Assessment With Ex Vivo Optical Coherence Tomography vol.131, pp.3, 2013, https://doi.org/10.1161/circulationaha.114.012658
  3. Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature vol.7, pp.4, 2016, https://doi.org/10.7150/jca.13611
  4. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs vol.8, pp.9, 2020, https://doi.org/10.1016/j.jaip.2020.08.006